SCHEMBL8288344

SCHEMBL8288344

COc1ccc(BO)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 3/20 0.48
▸ CA12 O43570 2/20 0.48
▸ CA1 P00915 2/20 0.48
▸ CA7 P43166 2/20 0.48
▸ CA9 Q16790 2/20 0.48
▸ CA14 Q9ULX7 2/20 0.48
▸ ACHE P22303 1/20 0.48
▸ TSHR P16473 3/20 0.47
▸ CYP1A2 P05177 3/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP1A1 P04798 5/20 0.46
▸ CYP1B1 Q16678 4/20 0.46
▸ CA4 P22748 1/20 0.45
▸ CA6 P23280 1/20 0.45
▸ TPMT P51580 1/20 0.45
▸ HTR3E A5X5Y0 1/20 0.44
▸ HTR3B O95264 1/20 0.44
▸ HTR3A P46098 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26447172 0.81 RAB9A (0.50) MEN1KMT2AALDH1A1MAPK1
SCHEMBL19523880 0.81 HTT (0.43) ACHEMEN1GAAKMT2AALDH1A1
SCHEMBL14201716 0.78 ALDH1A1 (0.52) TSHRALDH1A1HPGD
SCHEMBL22449752 0.77 APP (0.52) CA2CA12CA1CA7CA9
SCHEMBL7899795 0.74 CYP3A4 (0.56) CA9ACHECYP1A2CYP3A4CYP1A1
SCHEMBL25416873 0.70 PRKAB2 (0.42) —
SCHEMBL1402508 0.70 CA2 (0.56) CA2CA12CA1CA7CA9
SCHEMBL10224469 0.70 CA2 (0.61) CA2CA12CA1CA7CA9
SCHEMBL23192517 0.70 CYP1A2 (0.54) TSHRCYP1A2CYP1A1CYP1B1MEN1
SCHEMBL23158674 0.69 CA2 (0.39) CA2CA12CA1CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019209948-A9 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2020-01-02 — — WO disclosed
WO-2018081167-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS (US) 2018-05-03 — — WO disclosed
WO-2016006706-A1 PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYL METHYL GROUP 第一三共株式会社 2016-01-14 — — WO disclosed
WO-2014004863-A2 COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF ALZHEIMER'S INSTITUTE OF AMERICA, INC. (US) 2014-01-03 — — WO disclosed
WO-2009099801-A1 PYRIDO [4, 3-D] PYRIMIDINONE DERIVATIVES AS KINASE INHIBITORS IRM LLC (BM) 2009-08-13 — — WO disclosed
WO-2005040110-A1 PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS ELI LILLY AND COMPANY (US) 2005-05-06 — — WO disclosed
Send feedback